National Institutes of Health

Description

Purpose. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Office of Behavioral and Social Sciences Research (OBSSR) encourage NIH Clinical Trial Planning Grant Program grant (R34) applications from institutions/ organizations to develop and pilot test translational interventions for the prevention and control of diabetes and obesity that have a high potential to be adopted, and sustained in applied health care settings. Research must be based on widely accepted interventions previously demonstrated to be efficacious in clinical trials. Research must target the prevention or reversal of obesity, prevention of type 2 diabetes, improved care of type 1 and type 2 diabetes, or the prevention or delay of the complications of these conditions. The interventions proposed under this FOA should have the potential to be widely disseminated to clinical practice, individuals and communities at risk. Mechanism of Support. This FOA will utilize the NIH Clinical Trial Planning Grant Program (R34) grant mechanism and runs in parallel with a R18 FOA of identical scientific scope, PAR-09-176.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV